News

Award continues Kevin’s legacy of helping young people affected by ALS pursue their educational and career aspirations TORONTO, September 9, 2026 – The ALS Society of Canada (ALS Canada), together with the family and friends of Kevin Daly through…

Our bimonthly Clinical Research & Trials Update keeps you up to date on what’s happening in ALS clinical research. We unpack trial press releases, flag upcoming studies, and highlight important new publications, including care guidelines, long-term therapy data, and off-label treatment insights.  For other news on…

* Neurofilament light (NfL) is a protein released when neurons are damaged and can be detected in the cerebrospinal fluid and blood. In ALS, higher NfL levels are generally associated with more rapid disease progression, at a group level. In clinical…

Our bimonthly Fundamental Research Update keeps you informed about the latest advances in lab-based ALS research. We break down new studies using cellular and animal models, highlight progress on promising preclinical targets, breakdown trending research news, and showcase Canadian led science.  For other news on clinical research and trials, read our Clinical Research & Trials Updates.  ALS…

This blog series is a place for the ALS community to learn about and stay updated on ALS Canada's advocacy efforts as well as relevant developments within the government. Please note that because ALS Canada…

PrimeC, an investigational therapy by NeuroSense Therapeutics, combines two existing prescription drugs: the antibiotic ciprofloxacin and the anti‑inflammatory drug celecoxib. Together, they are thought to target three biological processes linked to ALS: inflammation in the brain, abnormal microRNA activity (small RNA molecules that help regulate…

An ALS diagnosis affects the entire family. As families adapt to changing circumstances and caregiving responsibilities, routines shift, and priorities evolve. Along the way, young people can miss out on some of the activities, friendships, and experiences that help shape…

The ALS Society of Canada (ALS Canada) is pleased to continue its collaboration with Shionogi Canada (previously Tanabe Pharma Canada) to advance excellence in ALS clinical care through The Shionogi Canada Fellowship (previously the Tanabe Pharma Canada Fellowship). This annual…